Polygynax®

Brand Innotech International

In stock 10000 Items

Available since: 2019-06-23

All payments are SSL encrypted
Full Refund if you haven't received your order
International shipping to the USA, UK and Europe

Clinical Pharmacology

Polygynax Virgo has a bactericidal effect on gram-positive (Staphylococus aureus, Corynebacteria, etc.) and Gram-negative microorganisms (Enterococus faecium, Enterobacter aerogenes, Escherichia coli, Hemophilus influenzae, Proteus vulgaris, Klebsiella pneumoniae, myco-jerry, in-jerry, Istha, Istherophilus influenzae, Heleophilus influenzae, Proteus vulgaris, Klebsiella pneumonia, Myco-arteries, in-jerry, in-jones. It has a fungicidal effect on pathogenic fungi, especially yeast-like genus Candida albicans, Cryptococcus, Hystoplasma. Improves trophic processes in the vaginal mucosa.

Indications

Treatment.
- non-specific, fungal, mixed vaginitis, vulvovaginitis and cervicovaginitis;

Prevention.
- before surgical intervention in the genital area;
- before intrauterine diagnostic procedures.

Composition

Active substances:Neomycin sulfate 35 000 IU, Polymyxin B sulfate 35 000 IU, Nystatin 100 000 IU;
Excipients:hydrogenated soybean oil, dimethicone 1000, Tephos 63: palmitic esters and stearic esters.
The composition of the capsule shell:gelatin, glycerol, dimethicone 1000, purified water.

Polygynax® is marketed under different brands and generic names, and comes in different dosage forms:

Brand name	Manufacturer	Country	Dosage form
Polygynax Virgo	Innotech International	France	emulsion
Polygynax	Innotech International	France	vaginal capsules

No customer reviews for the moment.

Write your review

Dosage and Administration

Adults: one injection into each nostril 3-5 times a day.
Children aged 2.5 to 15 years: one injection in each nostril 3 times a day.
The duration of treatment is 5-10 days.

Adverse reactions

Allergic reactions: rarely - skin manifestations.

simultaneous use of monoamine oxidase inhibitors;
suspicion of angle-closure glaucoma;
viral diseases;
kidney disease associated with albuminuria;
pregnancy;
breastfeeding period;
children's age (up to 2, 5 years);
hypersensitivity to the drug.

Drug interactions

Drug interaction due to the content of phenylephrine. With simultaneous use of guanethidine and drugs of this group, the hypertensive effect of phenylephrine is enhanced and, due to a decrease in sympathetic tone with guanethidine, prolonged mydriasis is possible. If this combination cannot be avoided, then a doctor’s observation is necessary.